Mercer Global Advisors’s 1Life Healthcare ONEM Stock Holding History

Mercer Global Advisors’s Portfolio ONEM Stock Details ONEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-19,151	Closed	-$320K	–	2087
2022 Q4	$320K	Sell	19,151 -4,048	-17%	-$68.4K	﹤0.01%	1469
2022 Q3	$398K	Buy	23,199 +4,983	+27%	+$78.2K	﹤0.01%	1249
2022 Q2	$143K	Buy	18,216 +157	+0.9%	+$1.35K	﹤0.01%	1688
2022 Q1	$200K	Buy	18,059 +57	+0.3%	+$638	﹤0.01%	1734
2021 Q4	$316K	Buy	18,002 +2	+0%	+$39	﹤0.01%	1432
2021 Q3	$365K	Buy	+18,000	New	+$463K	﹤0.01%	1334
2021 Q1	–	Sell	-18,000	Closed	-$786K	–	1692
2020 Q4	$786K	Buy	+18,000	New	+$615K	0.01%	695

Mercer Global Advisors's ONEM Position: Q1 2023 in Review

Mercer Global Advisors sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 19,151 shares — an estimated $320K sold.

Mercer Global Advisors first reported a position in ONEM in Q4 2020 and held it in 7 quarters. The position peaked at $786K in Q4 2020. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

Mercer Global Advisors reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
Mercer Global Advisors sold 19,151 1Life Healthcare shares in Q1 2023, an estimated $320K.
Mercer Global Advisors first reported a position in 1Life Healthcare in Q4 2020 and held it in 7 quarters.
Mercer Global Advisors's 1Life Healthcare position peaked at $786K in Q4 2020.
0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Mercer Global Advisors's 13F filing for Q1 2023, filed 16 May 2023.